| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |